AU2011202136B2 — Improved process for the production of a radioactive aerosol
Assigned to Cyclomedica Australia Pty Ltd · Expires 2013-01-31 · 13y expired
What this patent protects
A method for forming an inhalable isotope compound suitable for use in patient medical diagnosis, the method comprising the steps of: (a) electrolytic loading of a carbon 5 crucible with the isotope; (b) sublimating any isotope carrier in the crucible; (c) ablating the isotope in…
USPTO Abstract
A method for forming an inhalable isotope compound suitable for use in patient medical diagnosis, the method comprising the steps of: (a) electrolytic loading of a carbon 5 crucible with the isotope; (b) sublimating any isotope carrier in the crucible; (c) ablating the isotope in a carbon crucible, forming an ablation aerosol; (d) directly delivering the aerosol for immediate use by a patient. The isotope can comprise technetium. Elute technetium generator with saline 10 Charge electrolytic concentrator with eluate Load crucible by electrolysis Place crucible in generator 11 -Purge heating chamber with argon Remove sodium chlorlde by sublimation into argon Prepare patient for inhalation Ablate radionuclide from crucible into argon stream Patient inhalation 2 Image patient with gamma camera Fig. 1
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.